Ascendis Pharma Correlations

ASND Stock

USD 152.15 0.72 0.48%

The current 90-days correlation between Ascendis Pharma AS and Apellis Pharmaceuticals is 0.23 (i.e., Modest diversification). The correlation of Ascendis Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Ascendis Pharma Correlation With Market

Weak diversification

The correlation between Ascendis Pharma AS and DJI is 0.36 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ascendis Pharma AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving together with Ascendis Stock

0.66	DVAX	Dynavax Technologies	Pair Corr
0.62	VRNA	Verona Pharma PLC	Pair Corr
0.64	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Ascendis Stock

0.83	A	Agilent Technologies	Pair Corr
0.82	VCEL	Vericel Corp Ord	Pair Corr
0.81	VCYT	Veracyte	Pair Corr
0.77	DNLI	Denali Therapeutics Upward Rally	Pair Corr
0.76	DRTS	Alpha Tau Medical	Pair Corr
0.7	ME	23Andme Holding	Pair Corr
0.7	SABSW	SAB Biotherapeutics	Pair Corr
0.69	VERA	Vera Therapeutics	Pair Corr
0.62	CDIOW	Cardio Diagnostics	Pair Corr
0.58	VANI	Vivani Medical	Pair Corr
0.48	VERV	Verve Therapeutics Downward Rally	Pair Corr
0.48	VINC	Vincerx Pharma	Pair Corr
0.48	VKTX	Viking Therapeutics Buyout Trend	Pair Corr
0.35	DNTH	Dianthus Therapeutics	Pair Corr
0.32	DMAC	DiaMedica Therapeutics	Pair Corr
0.77	VYGR	Voyager Therapeutics	Pair Corr
0.76	ELAN	Elanco Animal Health	Pair Corr
0.74	VRDN	Viridian Therapeutics	Pair Corr
0.67	VRPX	Virpax Pharmaceuticals	Pair Corr
0.66	VTYX	Ventyx Biosciences	Pair Corr
0.66	VXRT	Vaxart Inc	Pair Corr
0.66	ELDN	Eledon Pharmaceuticals	Pair Corr
0.66	ELEV	Elevation Oncology	Pair Corr
0.62	VTRS	Viatris	Pair Corr
0.61	VRAX	Virax Biolabs Group	Pair Corr
0.5	VYNE	Vyne Therapeutics	Pair Corr
0.48	VRCA	Verrica Pharmaceuticals	Pair Corr
0.47	DYAI	Dyadic International	Pair Corr
0.4	VTGN	VistaGen Therapeutics	Pair Corr

Related Correlations Analysis

	APLS	BGNE	AKRO	BPMC	REPL	NUVL	VTYX	UTHR	ISEE	AMLX
APLS		0.0	-0.4	0.38	0.38	0.62	0.95	0.77	0.0	0.28	APLS
BGNE	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BGNE
AKRO	-0.4	0.0		0.11	0.53	0.28	-0.52	-0.2	0.0	-0.15	AKRO
BPMC	0.38	0.0	0.11		0.36	0.68	0.42	0.55	0.0	-0.16	BPMC
REPL	0.38	0.0	0.53	0.36		0.7	0.32	0.54	0.0	-0.15	REPL
NUVL	0.62	0.0	0.28	0.68	0.7		0.55	0.66	0.0	0.19	NUVL
VTYX	0.95	0.0	-0.52	0.42	0.32	0.55		0.76	0.0	0.23	VTYX
UTHR	0.77	0.0	-0.2	0.55	0.54	0.66	0.76		0.0	-0.09	UTHR
ISEE	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	ISEE
AMLX	0.28	0.0	-0.15	-0.16	-0.15	0.19	0.23	-0.09	0.0		AMLX
	APLS	BGNE	AKRO	BPMC	REPL	NUVL	VTYX	UTHR	ISEE	AMLX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VTYX	+ 0.95	APLS
UTHR	+ 0.77	APLS
UTHR	+ 0.76	VTYX
NUVL	+ 0.7	REPL
NUVL	+ 0.68	BPMC
UTHR	+ 0.66	NUVL

High negative correlations

VTYX	- 0.52	AKRO
AKRO	- 0.4	APLS
UTHR	- 0.2	AKRO
AMLX	- 0.16	BPMC
AMLX	- 0.15	REPL
AMLX	- 0.15	AKRO

Risk-Adjusted Indicators

There is a big difference between Ascendis Stock performing well and Ascendis Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ascendis Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
APLS	2.31	(0.44)	0.00	(0.44)	0.00	0.00	4.11	(4.54)	20.77
BGNE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AKRO	4.42	1.16	0.32	0.49	2.94	(6.12)	5.13	(5.24)	104.81
BPMC	2.26	0.10	0.03	0.01	2.49	(3.01)	5.87	(3.96)	26.30
REPL	2.95	(0.55)	0.00	0.83	0.00	0.00	5.86	(6.16)	23.59
NUVL	2.14	(0.16)	0.00	(0.21)	0.00	0.00	3.62	(4.12)	12.24
VTYX	3.37	(1.01)	0.00	(0.56)	0.00	0.00	6.88	(7.56)	27.07
UTHR	1.41	(0.22)	0.00	(1.00)	0.00	0.00	2.52	(3.52)	15.73
ISEE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AMLX	3.85	0.08	0.01	0.00	5.05	(3.75)	7.44	(9.09)	21.45

Ascendis Pharma Corporate Management

Michael LLM	Chief VP	Profile
Birgitte MD	Sr Affairs	Profile
Stina MD	Executive Oncology	Profile
Scott Holmes	Head Endocrinology	Profile
Timothy Lee	Director Relations	Profile
Nyssa Noyola	Vice Management	Profile
Jens Okkels	VP Devel	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC